United States
Former CIA director John Brennan's transition to private sector threatened with legal action by his shareholders

Former head of CIA, John Brennan, in May 2017.
Former head of CIA, John Brennan, in May 2017. © SAUL LOEB / AFP
ImmunityBio's shares have plunged by more than half after the FDA recently rejected approval of its cancer treatment, but its business prospects were already murky when Brennan joined the board. He also has positions at Kissinger Associates and WestExec Advisors, dubbed President's Joe Biden's 'Cabinet in Waiting' in the aftermath of his 2020 election. [...]
Published on 08.06.2023 at 04:00 GMT Reading time 4 minutes

Read this article here:

Further reading

Sign up for real-time alerts and be notified of new editions!  

Once registered, you will be notified by a short message on your computer or mobile phone as soon as a new edition of our publication or an alert is published. Stay informed anytime, anywhere!